«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

28卷

期数:

2022年03期

页码:

278-283

栏目:

基础医学

出版日期:

2022-05-20

文章信息/Info

Title:

Protective effect of polydatin on blood-brain barrier in mice after transient focal cerebral ischemia

文章编号:

1006-8147(2022)03-0278-06

作者:

刘洋¹; 李嘉民²; 陈荣³; 张祥建³

（1.天津市环湖医院神经内科，天津300350；2.石家庄市人民医院神经内科，石家庄050011；3.河北医科大学 第二医院神经内科，石家庄050000）

Author(s):

LIU Yang¹; LI Jia-min²; CHEN Rong³; ZHANG Xiang-jian³

（1.Department of Neurology，Tianjin Huanhu Hospital，Tianjin 300350，China；2. Department of Neurology，The First Hospital of Shijiazhuang City，Shijiazhuang 050011，China；3. Department of Neurology，The Second Hospital of Hebei Medical University， Shijiazhuang 050000，China）

关键词:

白藜芦醇苷; 脑缺血再灌注损伤; 血脑屏障; 内皮细胞; 紧密连接蛋白

Keywords:

polydatin; reperfusion injury; blood-brain barrier; endothelial cells; tight junction proteins

分类号:

R743.3

DOI:

-

文献标志码:

A

摘要:

目的：观察白藜芦醇苷（PD）对脑缺血再灌注损伤小鼠血脑屏障的保护作用及对紧密连接蛋白的影响。方法：CD-1 小鼠 （102 只）应用线栓法制作短暂性大脑中动脉闭塞（tMCAO）模型。随机将实验动物分成4 组：假手术组（28 只）、缺血再灌注 组（28只）、白藜芦醇苷低剂量组（30 mg/kg，18只），白藜芦醇苷高剂量组（60 mg/kg，28只）。于缺血再灌注后24 h 进行行为学评 分、TTC 染色、干湿重测定、伊文思蓝染色，应用Western 印迹、免疫荧光检测内皮细胞标志物血小板内皮细胞黏附分子-1（CD- 31）、紧密连接蛋白闭锁小带蛋白-1（ZO-1）、咬合蛋白（Occludin）、闭合蛋白-5（Claudin-5）的表达情况。结果：（1）与缺血再灌注 组相比，白藜芦醇苷高剂量组改善了缺血再灌注小鼠行为学评分、减少了脑梗死体积[（33.76%± 13.27%）vs.（57.47%±9.53%）， P<0.05]、减轻了缺血再灌注小鼠脑水肿程度[（75.62%±7.95%）vs.（85.72%±6.20%），P<0.05]、降低了伊文思蓝渗出量[（1.49±0.47） vs.（2.13±0.44），P<0.05]。（2）Western印迹结果显示白藜芦醇苷上调了ZO-1、Occludin、Claudin-5（均P<0.05）的表达水平。（3）免 疫荧光结果显示:白藜芦醇苷组上调了CD-31 在皮层缺血半暗带区的表达，且可见微血管形态相较缺血再灌注组更加光滑、完 整，同时白藜芦醇苷减少了ZO-1、Claudin-5 的破坏。结论：白藜芦醇苷的干预对缺血再灌注损伤小鼠起到了保护血脑屏障的作 用，上调了紧密连接蛋白ZO-1、Occludin、Claudin-5 的表达水平。

Abstract:

Objective：To investigate the protective effect of polydatin（PD）on the blood-brain barrier and tight junction proteins in ischemia-reperfusion mice. Methods：A total of 102 CD-1 mice were subjected to transient middle cerebral artery occlusion model（tMCAO）. The experimental animals were divided into 4 groups randomly：Sham group（n=28），tMCAO group（n=28），PD-L group（polydatin 30 mg/kg，n=18），PD-H group（polydatin 60 mg/kg，n=28）. Neurological deficit scores，2，3，5-triphenyltetrazolium chloride（TTC）， the standard wet-dry method，Evans blue exudation was evaluated 24 h after ischemia-reperfusion. Western blotting and immunofluorescence was applied to detect the expression level of endothelial cell markers platelet endothelial cell adhesion molecule-1（cd-31），tight junction protein atresia Band-1（ZO-1），occludin and claudin-5. Results：（1）Compared with the tMCAO group 24 h after tMCAO， the neurological deficit score was ameliorated，the infarct volume was reduced[（33.76%±13.27%）vs.（57.47%±9.53%），P<0.05]， the brain water content was reduced[（75.62%±7.95%）vs.（85.72%±6.20%），P<0.05]，the permeability of blood-brain barrier was de creased [（1.49±0.47）vs.（2.13±0.44），P<0.05] in PD-H group respectively.（2）Western blotting showed that the level of ZO-1，Occludin， Claudin-5，was up-regulated significantly in the PD group 24 h after operation，compared with tMCAO group（P<0.05，respectively）.（ 3） Immunofluorescence showed that the expression of CD-31 was up-regulated in the cortex ischemic penumbra，and the tube shape of microvascular was smoother and more complete than that of the tMCAO group. Meanwhile，the disruption of ZO-1 and Claudin-5 staining was reduced in the PD group，compared with tMCAO group. Conclusion：Polydatin administration shows the protective effect of blood-brain barrier inmicewith ischemia-reperfusion injury，meanwhile it can up-regulate the expression of ZO-1，Occludin，Claudin-5.

参考文献/References:

[1] WU S，WU B，LIUM，et al. Stroke in China：advances and challenges in epidemiology，prevention，and management[J]. Lancet Neurol，2019， 18（4）：394-405.
[2] KHATRI R，MCKINNEY A M，SWENSON B，et al. Blood-brain barrier， reperfusion injury，and hemorrhagic transformation in acute ischemic stroke[J]. Neurology，2012，79（13 Suppl 1）：S52-S57.
[3] NEUWELT E A，BAUER B，FAHLKE C，et al. Engaging neuroscience to advance translational research in brain barrier biology[J]. Nat Rev Neurosci，2011，12（3）：169-182.
[4] TANG K S，TAN J S. The protective mechanisms of polydatin in cerebral ischemia[J]. Eur J Pharmacol，2019，842：133-138.
[5] LONGA E Z，WEINSTEIN P R，CARLSON S，et al. Reversible middle cerebral artery occlusion without craniectomy in rats[J]. Stroke， 1989，20（1）：84-91.
[6] DU Q H，PENG C，ZHANG H. Polydatin：a review of pharmacology and pharmacokinetics[J]. Pharm Biol，2013，51（11）：1347-1354.
[7] REGEV-SHOSHANI G，SHOSEYOV O，BILKIS I，et al. Glycosylation of resveratrol protects it from enzymic oxidation[J]. Biochem J， 2003，374（Pt 1）：157-163.
[8] LI R P，WANG Z Z，SUN M X，et al. Polydatin protects learning and memory impairments in a rat model of vascular dementia[J]. Phytomedicine， 2012，19（8/9）：677-681.
[9] YAO J，WANG J Y，LIU L，et al. Polydatin ameliorates DSS-induced colitis in mice through inhibition of nuclear factor-kappaB activation[ J]. Planta Med，2011，77（5）：421-427.
[10] XU L Q，XIE Y L，GUI S H，et al. Polydatin attenuates d-galactoseinduced liver and brain damage through its anti-oxidative，anti-inflammatory and anti-apoptotic effects in mice[J]. Food Funct，2016， 7（11）：4545-4555.
[11] ZHANG L P，MA H J，BU H M，et al. Polydatin attenuates ischemia/ reperfusion-induced apoptosis in myocardium of the rat[J]. Sheng Li Xue Bao，2009，61（4）：367-372.
[12] JI H，ZHANG X，DU Y，et al. Polydatin modulates inflammation by decreasing NF-kappaB activation and oxidative stress by increasing Gli1，Ptch1，SOD1 expression and ameliorates blood -brain barrier permeability for its neuroprotective effect in pMCAO rat brain [J]. Brain Res Bull，2012，87（1）：50-59.
[13] CHENG Y，ZHANG H T，SUN L，et al. Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia - reperfusion injury[J]. Brain Res，2006，1110（1）：193-200.
[14] RUAN W，LI J，XU Y，et al. MALAT1 up-regulator polydatin protects brain microvascular integrity and ameliorates stroke through C/ EBPβ/MALAT1/CREB/PGC-1α/PPARγ pathway[J]. Cell Mol Neurobiol， 2019，39（2）：265-286.
[15] MARK K S，DAVIS T P. Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation[J]. Am J Physiol Heart Circ Physiol，2002，282（4）：H1485-H1494.
[16] GREENE C，HANLEY N，CAMPBELL M. Claudin-5：gate keeper of neurological function[J]. Fluids Barriers CNS，2019，16（1）：3.
[17] YUAN S，LIU K J，QI Z. Occludin regulation of blood-brain barrier and potential therapeutic target in ischemic stroke[J]. Brain Circ， 2020，6（3）：152-162.
[18] TORNAVACA O，CHIA M，DUFTON N，et al. ZO -1 controls endothelial adherens junctions，cell -cell tension，angiogenesis，and barrier formation[J]. J Cell Biol，2015，208（6）：821-838.
[19] PROFACI C P，MUNJI R N，PULIDO R S，et al. The blood -brain barrier in health and disease：important unanswered questions[J]. J Exp Med，2020，217（4）：e20190062.
[20] YANG Y，ROSENBERG G A. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease[J]. Stroke，2011，42（11）： 3323-3328.
[21] OSTERMANN G，WEBER K S，ZERNECKE A，et al. JAM-1 is a ligand of the beta （2）integrin LFA-1 involved in transendothelial migration of leukocytes[J]. Nat Immunol，2002，3（2）：151-158.
[22] BOLTON S J，ANTHONY D C，PERRY V H. Loss of the tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neutrophil -induced blood -brain barrier breakdown in vivo[J]. Neuroscience，1998，86（4）：1245-1257.
[23] CANDELARIO-JALIL E，TAHERI S，YANG Y，et al. Cyclooxygenase inhibition limits blood -brain barrier disruption following in － tracerebral injection of tumor necrosis factor-alpha in the rat[J]. J Pharmacol Exp Ther，2007，323（2）：488-498.
[24] GAO Y，CHEN T，LEI X，et al. Neuroprotective effects of polydatin against mitochondrial -dependent apoptosis in the rat cerebral cortex following ischemia/reperfusion injury[J]. Mol Med Rep，2016， 14（6）：5481-5488.

相似文献/References:

备注/Memo

备注/Memo:

基金项目河北省卫生健康委员会指令项目（20190061）
作者简介:刘洋（1989-），男，医师，硕士，研究方向：神经病学；
通信作者：张祥建，E-mail：zhang6xj@aliyun.com。

常用功能

更新日期/Last Update: 2022-06-01